APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic and Analgesic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antipyretic and Analgesic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchAntipyretic and Analgesic Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic and Analgesic Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Antipyretic and Analgesic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic and Analgesic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic and Analgesic Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Antipyretic and Analgesic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antipyretic and Analgesic Drugs include Yuanhe Pharmaceutical, Xinhui Pharmaceutical, Topfond Pharmaceutical, Taile Pharmaceutical, Sanofi, Pfizer, Kys Pharm, China Resources Double-Crane Pharmaceutical and Huaan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antipyretic and Analgesic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antipyretic and Analgesic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antipyretic and Analgesic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antipyretic and Analgesic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Antipyretic and Analgesic Drugs Segment by Company

Yuanhe Pharmaceutical

Xinhui Pharmaceutical

Topfond Pharmaceutical

Taile Pharmaceutical

Sanofi

Pfizer

Kys Pharm

China Resources Double-Crane Pharmaceutical

Huaan Pharmaceutical

Hongxing Pharmaceutical

Heping Pharmaceutical

China National Medicines Guorui Pharmaceutical

Dingchang Pharmaceutical

Baotai Pharmaceutical

Bayer

SKPL

Mallinckrodt

Antipyretic and Analgesic Drugs Segment by Type

Paracetamol

Naproxen

Ibuprofen

Analgin

Aspirin

Others

Antipyretic and Analgesic Drugs Segment by Application

Hospital

Clinic

Antipyretic and Analgesic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic and Analgesic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic and Analgesic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic and Analgesic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antipyretic and Analgesic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antipyretic and Analgesic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antipyretic and Analgesic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antipyretic and Analgesic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antipyretic and Analgesic Drugs Industry Trends Table 2. Antipyretic and Analgesic Drugs Industry Drivers Table 3. Antipyretic and Analgesic Drugs Industry Opportunities and Challenges Table 4. Antipyretic and Analgesic Drugs Industry Restraints Table 5. Global Antipyretic and Analgesic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antipyretic and Analgesic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antipyretic and Analgesic Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers Table 9. Global Antipyretic and Analgesic Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Antipyretic and Analgesic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antipyretic and Analgesic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antipyretic and Analgesic Drugs Manufacturers, Product Type & Application Table 13. Global Antipyretic and Analgesic Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antipyretic and Analgesic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Paracetamol Table 17. Major Manufacturers of Naproxen Table 18. Major Manufacturers of Ibuprofen Table 19. Major Manufacturers of Analgin Table 20. Major Manufacturers of Aspirin Table 21. Major Manufacturers of Others Table 22. Global Antipyretic and Analgesic Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 24. Global Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 25. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2026) Table 26. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2027-2032) Table 27. Global Antipyretic and Analgesic Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (k units) Table 29. Global Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (k units) Table 30. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Clinic Table 34. Global Antipyretic and Analgesic Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 36. Global Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 37. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2026) Table 38. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2027-2032) Table 39. Global Antipyretic and Analgesic Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (k units) Table 41. Global Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (k units) Table 42. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Antipyretic and Analgesic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Antipyretic and Analgesic Drugs Sales by Region (2021-2026) & (k units) Table 46. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021-2026) Table 47. Global Antipyretic and Analgesic Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Antipyretic and Analgesic Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 51. North America Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 52. Europe Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 54. Europe Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 61. Global Antipyretic and Analgesic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Antipyretic and Analgesic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Antipyretic and Analgesic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2027-2032) Table 66. Yuanhe Pharmaceutical Company Information Table 67. Yuanhe Pharmaceutical Business Overview Table 68. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 70. Yuanhe Pharmaceutical Recent Development Table 71. Xinhui Pharmaceutical Company Information Table 72. Xinhui Pharmaceutical Business Overview Table 73. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 75. Xinhui Pharmaceutical Recent Development Table 76. Topfond Pharmaceutical Company Information Table 77. Topfond Pharmaceutical Business Overview Table 78. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 80. Topfond Pharmaceutical Recent Development Table 81. Taile Pharmaceutical Company Information Table 82. Taile Pharmaceutical Business Overview Table 83. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 85. Taile Pharmaceutical Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sanofi Antipyretic and Analgesic Drugs Product Portfolio Table 90. Sanofi Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Pfizer Antipyretic and Analgesic Drugs Product Portfolio Table 95. Pfizer Recent Development Table 96. Kys Pharm Company Information Table 97. Kys Pharm Business Overview Table 98. Kys Pharm Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio Table 100. Kys Pharm Recent Development Table 101. China Resources Double-Crane Pharmaceutical Company Information Table 102. China Resources Double-Crane Pharmaceutical Business Overview Table 103. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 105. China Resources Double-Crane Pharmaceutical Recent Development Table 106. Huaan Pharmaceutical Company Information Table 107. Huaan Pharmaceutical Business Overview Table 108. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 110. Huaan Pharmaceutical Recent Development Table 111. Hongxing Pharmaceutical Company Information Table 112. Hongxing Pharmaceutical Business Overview Table 113. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 115. Hongxing Pharmaceutical Recent Development Table 116. Heping Pharmaceutical Company Information Table 117. Heping Pharmaceutical Business Overview Table 118. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 120. Heping Pharmaceutical Recent Development Table 121. China National Medicines Guorui Pharmaceutical Company Information Table 122. China National Medicines Guorui Pharmaceutical Business Overview Table 123. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 125. China National Medicines Guorui Pharmaceutical Recent Development Table 126. Dingchang Pharmaceutical Company Information Table 127. Dingchang Pharmaceutical Business Overview Table 128. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 130. Dingchang Pharmaceutical Recent Development Table 131. Baotai Pharmaceutical Company Information Table 132. Baotai Pharmaceutical Business Overview Table 133. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 135. Baotai Pharmaceutical Recent Development Table 136. Bayer Company Information Table 137. Bayer Business Overview Table 138. Bayer Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Bayer Antipyretic and Analgesic Drugs Product Portfolio Table 140. Bayer Recent Development Table 141. SKPL Company Information Table 142. SKPL Business Overview Table 143. SKPL Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. SKPL Antipyretic and Analgesic Drugs Product Portfolio Table 145. SKPL Recent Development Table 146. Mallinckrodt Company Information Table 147. Mallinckrodt Business Overview Table 148. Mallinckrodt Antipyretic and Analgesic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio Table 150. Mallinckrodt Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Antipyretic and Analgesic Drugs Distributors List Table 154. Antipyretic and Analgesic Drugs Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Antipyretic and Analgesic Drugs Product Image Figure 2. Global Antipyretic and Analgesic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antipyretic and Analgesic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antipyretic and Analgesic Drugs Sales (2021-2032) & (k units) Figure 5. Global Antipyretic and Analgesic Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antipyretic and Analgesic Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Paracetamol Image Figure 9. Naproxen Image Figure 10. Ibuprofen Image Figure 11. Analgin Image Figure 12. Aspirin Image Figure 13. Others Image Figure 14. Global Antipyretic and Analgesic Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Antipyretic and Analgesic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2032) Figure 17. Global Antipyretic and Analgesic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Antipyretic and Analgesic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Global Antipyretic and Analgesic Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Antipyretic and Analgesic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Antipyretic and Analgesic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Antipyretic and Analgesic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 42. China Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Antipyretic and Analgesic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Antipyretic and Analgesic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Antipyretic and Analgesic Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Antipyretic and Analgesic Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Antipyretic and Analgesic Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Paracetamol
  • Naproxen
  • Ibuprofen
  • Analgin
  • Aspirin
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuanhe Pharmaceutical
  • Xinhui Pharmaceutical
  • Topfond Pharmaceutical
  • Taile Pharmaceutical
  • Sanofi
  • Pfizer
  • Kys Pharm
  • China Resources Double-Crane Pharmaceutical
  • Huaan Pharmaceutical
  • Hongxing Pharmaceutical
  • Heping Pharmaceutical
  • China National Medicines Guorui Pharmaceutical
  • Dingchang Pharmaceutical
  • Baotai Pharmaceutical
  • Bayer
  • SKPL
  • Mallinckrodt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antipyretic and Analgesic Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antipyretic and Analgesic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antipyretic and Analgesic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antipyretic and Analgesic Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antipyretic and Analgesic Drugs Market Dynamics
  1. 2.1 Antipyretic and Analgesic Drugs Industry Trends
  2. 2.2 Antipyretic and Analgesic Drugs Industry Drivers
  3. 2.3 Antipyretic and Analgesic Drugs Industry Opportunities and Challenges
  4. 2.4 Antipyretic and Analgesic Drugs Industry Restraints
3 Antipyretic and Analgesic Drugs Market by Manufacturers
  1. 3.1 Global Antipyretic and Analgesic Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antipyretic and Analgesic Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antipyretic and Analgesic Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antipyretic and Analgesic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antipyretic and Analgesic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antipyretic and Analgesic Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Antipyretic and Analgesic Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antipyretic and Analgesic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antipyretic and Analgesic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antipyretic and Analgesic Drugs Tier 1, Tier 2, and Tier 3
4 Antipyretic and Analgesic Drugs Market by Type
  1. 4.1 Antipyretic and Analgesic Drugs Type Introduction
  2. 4.1.1 Paracetamol
  3. 4.1.2 Naproxen
  4. 4.1.3 Ibuprofen
  5. 4.1.4 Analgin
  6. 4.1.5 Aspirin
  7. 4.1.6 Others
  8. 4.2 Global Antipyretic and Analgesic Drugs Sales by Type
  9. 4.2.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Antipyretic and Analgesic Drugs Sales by Type (2021-2032)
  11. 4.2.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2032)
  12. 4.3 Global Antipyretic and Analgesic Drugs Revenue by Type
  13. 4.3.1 Global Antipyretic and Analgesic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2021-2032)
  15. 4.3.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2032)
5 Antipyretic and Analgesic Drugs Market by Application
  1. 5.1 Antipyretic and Analgesic Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Antipyretic and Analgesic Drugs Sales by Application
  5. 5.2.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antipyretic and Analgesic Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Antipyretic and Analgesic Drugs Revenue by Application
  9. 5.3.1 Global Antipyretic and Analgesic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2032)
6 Global Antipyretic and Analgesic Drugs Sales by Region
  1. 6.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antipyretic and Analgesic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Antipyretic and Analgesic Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Antipyretic and Analgesic Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antipyretic and Analgesic Drugs Revenue by Region
  1. 7.1 Global Antipyretic and Analgesic Drugs Revenue by Region
  2. 7.1.1 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antipyretic and Analgesic Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Antipyretic and Analgesic Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antipyretic and Analgesic Drugs Revenue (2021-2032)
  8. 7.2.2 North America Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antipyretic and Analgesic Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antipyretic and Analgesic Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antipyretic and Analgesic Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antipyretic and Analgesic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuanhe Pharmaceutical
  2. 8.1.1 Yuanhe Pharmaceutical Company Information
  3. 8.1.2 Yuanhe Pharmaceutical Business Overview
  4. 8.1.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  6. 8.1.5 Yuanhe Pharmaceutical Recent Developments
  7. 8.2 Xinhui Pharmaceutical
  8. 8.2.1 Xinhui Pharmaceutical Company Information
  9. 8.2.2 Xinhui Pharmaceutical Business Overview
  10. 8.2.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  12. 8.2.5 Xinhui Pharmaceutical Recent Developments
  13. 8.3 Topfond Pharmaceutical
  14. 8.3.1 Topfond Pharmaceutical Company Information
  15. 8.3.2 Topfond Pharmaceutical Business Overview
  16. 8.3.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  18. 8.3.5 Topfond Pharmaceutical Recent Developments
  19. 8.4 Taile Pharmaceutical
  20. 8.4.1 Taile Pharmaceutical Company Information
  21. 8.4.2 Taile Pharmaceutical Business Overview
  22. 8.4.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  24. 8.4.5 Taile Pharmaceutical Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Antipyretic and Analgesic Drugs Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Antipyretic and Analgesic Drugs Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Kys Pharm
  38. 8.7.1 Kys Pharm Company Information
  39. 8.7.2 Kys Pharm Business Overview
  40. 8.7.3 Kys Pharm Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio
  42. 8.7.5 Kys Pharm Recent Developments
  43. 8.8 China Resources Double-Crane Pharmaceutical
  44. 8.8.1 China Resources Double-Crane Pharmaceutical Company Information
  45. 8.8.2 China Resources Double-Crane Pharmaceutical Business Overview
  46. 8.8.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  48. 8.8.5 China Resources Double-Crane Pharmaceutical Recent Developments
  49. 8.9 Huaan Pharmaceutical
  50. 8.9.1 Huaan Pharmaceutical Company Information
  51. 8.9.2 Huaan Pharmaceutical Business Overview
  52. 8.9.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  54. 8.9.5 Huaan Pharmaceutical Recent Developments
  55. 8.10 Hongxing Pharmaceutical
  56. 8.10.1 Hongxing Pharmaceutical Company Information
  57. 8.10.2 Hongxing Pharmaceutical Business Overview
  58. 8.10.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  60. 8.10.5 Hongxing Pharmaceutical Recent Developments
  61. 8.11 Heping Pharmaceutical
  62. 8.11.1 Heping Pharmaceutical Company Information
  63. 8.11.2 Heping Pharmaceutical Business Overview
  64. 8.11.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  66. 8.11.5 Heping Pharmaceutical Recent Developments
  67. 8.12 China National Medicines Guorui Pharmaceutical
  68. 8.12.1 China National Medicines Guorui Pharmaceutical Company Information
  69. 8.12.2 China National Medicines Guorui Pharmaceutical Business Overview
  70. 8.12.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  72. 8.12.5 China National Medicines Guorui Pharmaceutical Recent Developments
  73. 8.13 Dingchang Pharmaceutical
  74. 8.13.1 Dingchang Pharmaceutical Company Information
  75. 8.13.2 Dingchang Pharmaceutical Business Overview
  76. 8.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  78. 8.13.5 Dingchang Pharmaceutical Recent Developments
  79. 8.14 Baotai Pharmaceutical
  80. 8.14.1 Baotai Pharmaceutical Company Information
  81. 8.14.2 Baotai Pharmaceutical Business Overview
  82. 8.14.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  84. 8.14.5 Baotai Pharmaceutical Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Antipyretic and Analgesic Drugs Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 SKPL
  92. 8.16.1 SKPL Company Information
  93. 8.16.2 SKPL Business Overview
  94. 8.16.3 SKPL Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 SKPL Antipyretic and Analgesic Drugs Product Portfolio
  96. 8.16.5 SKPL Recent Developments
  97. 8.17 Mallinckrodt
  98. 8.17.1 Mallinckrodt Company Information
  99. 8.17.2 Mallinckrodt Business Overview
  100. 8.17.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio
  102. 8.17.5 Mallinckrodt Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antipyretic and Analgesic Drugs Value Chain Analysis
  2. 9.1.1 Antipyretic and Analgesic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antipyretic and Analgesic Drugs Production Mode & Process
  6. 9.2 Antipyretic and Analgesic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antipyretic and Analgesic Drugs Distributors
  9. 9.2.3 Antipyretic and Analgesic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst